<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>On AIDS Drugs, a Mixed Blessing</title>
    <meta content="LTR230117" name="slug"/>
    <meta content="22" name="publication_day_of_month"/>
    <meta content="5" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Monday" name="publication_day_of_week"/>
    <meta content="Editorial Desk" name="dsk"/>
    <meta content="18" name="print_page_number"/>
    <meta content="A" name="print_section"/>
    <meta content="5" name="print_column"/>
    <meta content="Opinion" name="online_sections"/>
    <docdata>
      <doc-id id-string="1201622"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Acquired Immune Deficiency Syndrome</classifier>
        <classifier class="indexing_service" type="descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="indexing_service" type="descriptor">Third World and Developing Countries</classifier>
        <classifier class="indexing_service" type="descriptor">Prices (Fares, Fees and Rates)</classifier>
        <classifier class="indexing_service" type="descriptor">Generic and Brand Name Products</classifier>
        <location class="indexing_service">Africa</location>
        <person class="indexing_service">Simmons, David</person>
        <classifier class="online_producer" type="types_of_material">Letter</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion/Letters</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Features/Travel/Guides/Destinations/Africa</classifier>
        <classifier class="online_producer" type="general_descriptor">Third World and Developing Countries</classifier>
        <classifier class="online_producer" type="general_descriptor">Acquired Immune Deficiency Syndrome</classifier>
        <classifier class="online_producer" type="general_descriptor">Acquired Immune Deficiency Syndrome</classifier>
        <classifier class="online_producer" type="general_descriptor">Generic and Brand Name Products</classifier>
        <classifier class="online_producer" type="general_descriptor">Prices (Fares, Fees and Rates)</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Viruses</classifier>
        <classifier class="online_producer" type="general_descriptor">Diseases and Conditions</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
        <classifier class="online_producer" type="general_descriptor">Politics and Government</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000522T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9504E1DC1E3AF931A15756C0A9669C8B63" item-length="123" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>On AIDS Drugs, a Mixed Blessing</hl1>
      </hedline>
      <abstract>
        <p>Letter from David Simmons says drug companies' offer to cut price of AIDS drugs for Africa does little to stimulate poor countries' rights to produce inexpensive quality drugs</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>To the Editor:</p>
        <p>Re ''Cheaper Drugs to Combat AIDS'' (editorial, May 15):</p>
        <p>Regarding drug companies' offer to negotiate steep cuts in the price of AIDS drugs for Africa, this humanitarian effort offers too little too late.  In addition, the agreement does little to stimulate poor countries' rights to produce inexpensive quality drugs.</p>
      </block>
      <block class="full_text">
        <p>To the Editor:</p>
        <p>Re ''Cheaper Drugs to Combat AIDS'' (editorial, May 15):</p>
        <p>Regarding drug companies' offer to negotiate steep cuts in the price of AIDS drugs for Africa, this humanitarian effort offers too little too late.  In addition, the agreement does little to stimulate poor countries' rights to produce inexpensive quality drugs.</p>
        <p>While an apparently benevolent gesture, the end result could be a further consolidation of the AIDS drug market among a cabal of multinational pharmaceutical companies. Moreover, it may undermine the production capacity of these drugs in developing countries.</p>
        <p>DAVID  SIMMONS  Okemos, Mich., May 15, 2000</p>
        <p>The writer is a medical anthropologist at Michigan State University specializing in infectious diseases in Africa.</p>
      </block>
    </body.content>
  </body>
</nitf>
